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Abstract
Background: Risk adjustment and stratification play an important role in quality assurance and in
clinical research. The Physiological and Operative Severity Score for the enUmeration of Mortality
and morbidity (POSSUM) is a patient risk prediction model based on 12 patient characteristics and
6 characteristics of the surgery performed. However, because the POSSUM was developed for
quality assessment in general surgical units, its performance within specific subgroups still requires
evaluation.
The aim of the present study was to assess the accuracy of POSSUM in predicting mortality and
morbidity in patients with gastric cancer undergoing D2-gastrectomy.
Methods: 137 patients with gastric cancer undergoing gastrectomy were included in this study.
Detailed, standardized risk assessments and thorough documentation of the post-operative
courses were performed prospectively, and the POSSUM scores were then calculated.
Results: The 30- and 90- day mortality rates were 3.6% (n = 5) and 5.8% (n = 8), respectively.
65.7% (n = 90) of patients had normal postoperative courses without major complications, 14.6%
(n = 20) had moderate and 13.9% (n = 19) had severe complications. The number of mortalities
predicted by the POSSUM-Mortality Risk Score (R1) was double the actual number of mortalities
occurring in the median and high-risk groups, and was more than eight times the actual number of
mortalities occurring in the low-risk group (R1 < 20%). However, the calculated R1 predicted
rather well in terms of severe morbidity or post-operative death in each risk group: in predicted
low risk patients the actual occurrence rate (AR) of severe morbidity or post-operative death was
14%, for predicted medium risk patients the AR was 23%, and for predicted high risk patients the
AR was 50% (p < 0.05). The POSSUM-Morbidity Risk Score (R2) overestimated the risk of
morbidity.
Conclusion: The POSSUM Score may be beneficial and can be used for assessment of the peri-
and post-operative courses of patients with gastric carcinoma undergoing D2-gastrectomy.
However, none of the scores examined here are useful for preoperative prediction of
postoperative course.
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Risk adjustment and stratification play an important role
in quality assurance and are indispensable tools used in
clinical research. The Physiological and Operative Severity
Score for the enUmeration of Mortality and morbidity
(POSSUM) is a patient risk prediction model based on 12
patient characteristics and 6 characteristics of the surgery
performed [1]. However, because the POSSUM model was
developed for quality assessment purposes in general sur-
gical units, in order to implement it for specific subgroups
of patients, its performance within such subgroups needs
to be evaluated. The results of two prospective studies
[2,3] showed higher mortality and morbidity rates after
D2-lymphadenectomy (LAD) than after D1-lym-
phadenectomy for patients with gastric cancer, although
there is apparently no difference in the long-term prog-
noses for patients after the two procedures [4,5]. How-
ever, for certain patient subgroups, radical lymph node
(LN) dissection does improve prognosis. For this reason,
it would be greatly beneficial to calculate the risks of mor-
bidity and mortality for each patient preoperatively. In
addition, for prognostic studies it would be useful to be
able to stratify patients according to their risk factors.
In some countries, the American Society of Anesthesiolo-
gists' (ASA) classification is widely used to provide quality
assurance of surgical procedures [6,7]. The ASA-score is
easy to use, but the classification is not precise [8], and it
does not consider the severity of surgical insult. POSSUM
has been used to make comparisons between different
vascular [9,10] and colorectal [11] surgical units, and to
compare individual surgeons' performance within a single
unit [12,13].
The aim of the present study was to assess the accuracy of
the POSSUM instrument to predict mortality and morbid-




All patients with gastric cancer undergoing total gastrec-
tomy (n = 123) or subtotal gastrectomy (n = 16) at the
Department of Surgery, University of Cologne between
January 1, 1997 and December 31, 2001 were included in
this study. Preoperatively, all patients underwent
esophago-gastro-duodenoscopy with biopsies and his-
topathologic examination. In addition, endosonography
of the stomach was performed to stage the depth of
tumour infiltration (T-category), and CT-scans were done
to look for evidence of metastases.
Surgical procedure and extent of lymphadenectomy
In all cases an en bloc resection of the stomach with
extended D2-lymphadenectomy was performed. The
lymph node dissection included compartments I and II.
Compartment I comprises all lymph node groups along
the lesser curvature (No.s 1,3 and 5) and the greater cur-
vature (No.s 2, 4, and 6) of the stomach. Compartment II
comprises lymph node stations 7 to 12 according to the
General Rules for the Gastric Cancer Study in Surgery and
Pathology [14]. Type II (cardia) and type III (subcardial)
adenocarcinomas of the gastroesophageal junction (using
the Siewert/Hölscher classification system) [15] were
treated with a trans-hiatal extended gastrectomy including
D2-lymphadenectomy and lymph node dissection of the
lower mediastinum. In the cases of subtotal gastrectomy
(n = 16), only lymph node stations 3 to 6 (compartment
I) and lymph node stations 7 to 12 (compartment II) were
resected en bloc. Sampling of compartments III and IV
nodes (No. 13 to 16) was optional. The surgeon divided
the en bloc resected tissue containing lymph nodes into
separate stations and assigned numbers to these stations
according to the Japanese classification system [14].
Splenectomy was performed (n = 35) in cases of proximal
gastric carcinoma (types II and III) and in cases of meta-
static infiltration of the splenic hilar nodes (No. 10), but
not as a general rule [16].
Risk assessment
The selection of patients for surgery was based on the sur-
geons' "end of the bed assessment" backed by a detailed
risk analysis described elsewhere [17,18]. This risk analy-
sis has been evaluated in a prospective study. All data were
routinely available. Ninety-two per cent of the operations
were performed by four surgeons specializing in upper
gastrointestinal surgery. Two patients were excluded from
the study owing to incomplete data despite extensive
tracking of case notes. The remaining 137 patients were
scored retrospectively using the POSSUM-score, and the
predicted risk of morbidity and death was calculated for
each patient according to the following previously
described logistic regression equations [1]: log e [R1/(1 -
R1)] = - 7.04 + (0.13 × physiological score) + (0.16 × oper-
ative severity score) where R1 = risk of death, and log e
[R2/(1 - R2)] = - 5.91 + (0.16 × physiological score) +
(0.19 × operative severity score) where R2 = risk of
morbidity.
Because the equations for R1 and R2 require information
about the operative insult severity, and this data was not
available preoperatively, we also calculated the physiolog-
ical score (PPS) and in addition the V-POSSUM [19],
which uses only the physiological score: log e [R3/(1 -
R3)] = - 6.0386 + (0.1539 × physiological score), where R3
= risk of death.Page 2 of 7
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McPeek Index 4 – 6 [20]):
1 = normal course of disease: Patient had no significant
surgical or general postoperative complications.
2 = moderately favorable course of disease: Patient had
postoperative complications, but the complications were
treatable with appropriate therapy.
3 = poor course of disease: Patient had multiple complica-
tions that were difficult to treat with any kind of therapy.
4 = Died as a consequence of surgery (90-day mortality).
Definition of postoperative morbidity
Pulmonary complications: Emphysema, pneumothorax,
acute pneumonia, aspiration.
Cardiac complications: Cardiovascular collapse, cardiac
decompensation, bradycardia, myocardial infarction,
hypertensive or hypotensive cardiovascular crisis.
Cerebral complications: Cerebral infarction, cerebral
edema, organic brain syndrome.
Renal complications: Renal failure, renal bleeding, uri-
nary tract infection.
In computing post-operative mortality, deaths occurring
in and outside of the hospital were not differentiated [21].
Complications were documented using a detailed ques-
tionnaire. The severity of the post-operative course was
evaluated by the treating physician while the patient was
undergoing intensive care. Evaluations were based on the
overall clinical impression and did not necessarily depend
on the precise number of complications.
The observed and predicted operative mortality rates were
compared using frequency tables. Model performance was
evaluated with the Hosmer-Lemeshow 2 statistic (HL),
which is a measure of calibration or goodness of fit [22].
Calibration refers to the ability of the model to assign cor-
rect outcome probabilities to patients, i.e. whether the
model-estimated probability of mortality for patients
with particular risk factors agrees with the actual observed
mortality rate. To obtain this statistic, the estimated prob-
ability of death for each patient was computed based on
the model and then stratified into different groups. The
numbers of predicted and observed outcomes for each
group were then evaluated statistically. Higher values of
the HL statistic represent poorer model calibration.
Table 1: Clinico-patho logic data of 137 patients with gastric 
cancer and gastrectomy with D2-lym phadenectomy.
median age 65 y range (38 – 85 y)
gender: m:f 3:2
pT-categ ory n = 137 %
pT1 28 20, 4
pT2 46 33, 6
pT3 52 38, 0
pT4 11 8,0
pN-categ ory n = 137 %
pN0 47 34, 3
pN+ 90 65, 7
pM0 n = 108 78, 8 %
UICC-stage n = 137 %
Stage IA 20 14, 6
Stage IB 23 16, 8
Stage II 27 19, 6
Stage IIIA 15 11, 0
Stage IIIB 9 6, 6
Stage IV 43 31, 4
Location of tumour n = 137 %
Upper third 67 48, 9
Middle third 29 21, 2
Distal third 41 29, 9
Table 2: List of surgical and systemic complications in 137 
patients with gastrectomy and D2-lymphadenectomy. Multiple 
complications are possible.
total Postoperative Course
1 2 3 4
Surgical complications n % n n n n
Relaparotomy 5 3.6 - 1 2 2
Perforation 2 1.5 - 1 - 1
Anastomic leakage 7 5.1 1 3 2 1
secondary 1 0.7 - 1 - -
haemorrhage
Ileus 2 1.4 - - 1 1
Pancreatitis 5 3.6 - - 3 2
Peritonitis 5 3.6 - 1 1 3
Wound infection 8 5.8 2 1 2 3
Abscess 3 2.2 - 1 1 1
Pancreatic fistula 13 9.4 1 8 4 -
Catheter infection 5 3.6 - 2 3 -
Systemic complications
Reanimation 6 4.4 - - 2 4
Sepsis 7 5.1 - 1 2 4
pulmonary compl. 22 16.0 2 7 9 4
cardiac compl. 23 16.8 2 4 10 7
renal compl. 5 3.6 1 1 1 2
cerebral compl. 6 4.4 1 2 2 1
Other compl. 10 7.3 6 2 2 0Page 3 of 7
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of 5 per cent. The Chi-Square test was calculated using the
Yates correction. All calculations were performed using
the computer software package SPSS © version 11 for Win-
dows (SPSS, Chicago, Illinois, USA).
Graphical presentation of results was done with Sigma-
Plot Version 8.0.
Results
The epidemiologic data of the 137 patients are shown in
table 1. The mean number of resected lymph nodes was
37.7. The number of metastatic lymph nodes was an aver-
age of 7.6 (min: 0, max: 48). The median postoperative
stay in the Intensive Care Unit was 1 day (min 1, max 30),
and the median postoperative stay in the hospital was 17
days (min: 8 max 103).
Postoperative course
The 30-day mortality rate was 3.6% (n = 5) and the 90-day
mortality rate was 5.8% (n = 8). 65.7% (n = 90) of
patients had normal postoperative courses without major
complications. 14.6% (n = 20) had a medium postopera-
tive course and 13.9% (n = 19) experienced severe compli-
cations during the postoperative period. The list of
surgical and systemic complications is shown in table 2.
POSSUM-Score
Calculation of the POSSUM-Mortality Risk (R1) is shown
in table 3. The number of mortalities predicted by the cal-
culated R1 value was double the actual number of mortal-
ities occurring in the median and high-risk groups, and
was more than eight times the actual number of mortali-
ties occurring in the low-risk group (R1 < 20%). The
calculated R1 was much better as an estimate of severe
morbidity or post-operative death, however, with pre-
dicted values matching the number of observed cases. For
patients in the low-risk group (predicted risk 0 – 20%),
the actual rate of severe morbidity or post-operative death
was 14%; for patients in the median risk group (predicted
risk 21 – 40%), the actual rate observed was 23%; and for
patients in the high-risk group (predicted risk > 40%), the
actual rate of severe morbidity or post-operative death was
50%. The observed rates of morbidity and mortality dif-
fered significantly between the three groups (p < 0.05).
The POSSUM Morbidity equation (R2) predicted nearly
twice as many cases of mild or severe morbidity (includ-
ing death) than were actually observed (table 4). Only for
patients with a very low risk (R2 < 40%) or very high-risk
(R2 > 90%), predictions were good. However, for patients
with a calculated R2 less than or equal to 60% (low-risk
group), 19.1% (9 of 47) actually developed complications
or died after D2-resection, and for patients with higher
calculated R2 values >60% (high-risk group), 42.2% (38
of 90) actually did so. The observed morbidity and mor-
tality (for outcomes 2–4 defined above) differed
significantly between these low and high-risk groups (p <
0.01). There was no significant difference measured for
outcomes 3 and 4, but the test lacked sufficient power.
However, for cases of pre-operative predictions of post-
operative course using the POSSUM score, only physio-
logic criteria and not operative data are available for cal-
culations. Therefore, we used the POSSUM Physiological
Score (PPS) for outcome prediction. To assess the predic-
tive value of the PPS, we used logistic regression analysis.
Worse outcomes appeared to occur more frequently in
Table 3: Results of POSSUM Mortality calculation (R1) compared to observed mortality (outcome 4) and to the rate of severe 
morbidity and death (outcome 3 +4) in 137 patients with gastrectomy and D2-lymphadenectomy.
Possum Mortality 
Risk (R1)
patients expected death observed death 
outcome = 4
Observed morbidity and death 
outcome = 3+4
(%) n n n % n %
0–10 21 1 0 0 3 14,3
38675 51 7 1 2,0 7 13,7
low risk 0 – 20 72 1 1, 0 10 13, 9
21–30 38 9 3 7,8 9 23,7
31–40 19 6 2 10,5 4 21,1
med risk 21–40 57 5 8, 8 13 22, 8
41–60 4 1 1 25,0 1 25,0
71–100 4 2 1 25,0 3 75,0
high risk > 40 8 2 25, 0 4 50, 0
total 137 29 8 27Page 4 of 7
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was not statistically significant. The correlation between
patient age, PPS-score, and mortality is shown in figure 1.
There was no significant correlation between predicted
risk and actual post-operative course using the calculated
V-POSSUM score (data is not shown).
Discussion
For patients with gastric cancer, especially in advanced
stages, extensive lymphadenectomy (LAD) can improve
prognosis. The results of the Dutch prospective rand-
omized study show comparable long-term outcomes for
patients undergoing either D1- or D2-lymphadenectomy
[23]. However, this study also demonstrated an increased
rate of morbidity and mortality for patients undergoing
D2-LAD versus D1-LAD [4]. Therefore, it is important to
know pre-operatively which patients are more likely to
benefit from the more radical operation. Furthermore, in
order to compare study results for outcomes, it is neces-
sary to stratify the investigated patients according to risk
profiles.
Patients with gastric carcinoma are usually older than 60
years of age and have corresponding concomitant medical
problems, which may significantly influence the post-
operative course. For example in our study, 6 of the 8 post-
operative mortalities occurred in patients between 70 and
80 years of age. The risks for such older patients could be
only partially evaluated using the POSSUM Physiologic
Score (PPS). The lack of significant correlation between
higher PPS scores and higher risk for older patients may
be due to the small number of participants in this study.
There are various established assessment systems
designed to assess the gravity of pre-existing illnesses. The
ASA-Classification Score, for example, is used most often
Table 4: Results of POSSUM morbidity calculation (R2) compared to morbidity rate (outcome 2, 3 and 4) of 137 patients with 
gastrectomy and D2-lymphadenectomy.
POSSUM Risk of Morbidity R2 Patients Expected 
morbidity
observed severe morbidity and mortality 
Outcome (3 + 4)
observed morbidity and mortality 
Outcome (2 – 4)
% n n n % n %
0 – 30 2 0 0 0 0 0
31 – 40 12 3,9 3 25,0 4 25,0
41 – 50 14 6,6 1 7,1 2 14,3
50 – 60 19 10,6 2 10,5 3 15,8
low risk 0 – 60 47 6 12, 8 9 19, 1
61 – 70 21 14,9 2 9,5 8 38,1
71 – 80 35 25,7 7 20,0 14 40,0
81 – 90 28 22,4 7 25,0 10 35,7
91–100 6 5,7 5 83,3 6 100,0
high risk > 60 90 21 23, 3 38 43, 3
Total 137 27 47
Correlation between age of the patients, POSSUM Physiolog-ical Score (PPS) and the p stoper ive course of 137 patients with gastrectomy and D2-lym haden ct my: M = case with postoperative ortality, size of circl s hows the number f cases wi h the s m  PPSFigure 1
Correlation between age of the patients, POSSUM Physiolog-
ical Score (PPS) and the postoperative course of 137 patients 
with gastrectomy and D2-lymphadenectomy: M = case with 
postoperative mortality, size of circles shows the number of 
cases with the same PPS.Page 5 of 7
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This score was developed by anesthesiologists to consider
the risks of anesthetic procedure. It functions well as a fast
assessment of patients, and should ascertain whether a
life-threatening condition exists or whether peri-operative
problems can be expected. However, the ASA-score is less
suitable to determine whether a patient will develop seri-
ous complications as a result of the magnitude of the
operation performed [8]. In our study, half of the patients
were classified as ASA II, and half as ASA III. This risk strat-
ification correlated only weakly with the patients' actual
post-operative course.
The POSSUM Score has been evaluated in numerous stud-
ies [1,10-13,24]. The main objective in these studies was
to ascertain whether this score is suitable to evaluate the
Case-Mix [1,10,13,19]. It has also been used to assess sur-
geon-dependent risk factors [12,13]. A number of studies
have evaluated the applicability of the POSSUM Score for
particular medical conditions, and therefore a number of
varieties have emerged, i.e. the P-Possum-Score [25] or the
V-POSSUM-Score [19]. As shown in the foregoing results,
the POSSUM Mortality Index (R1) calculated the proba-
bility of mortality for patients with gastric carcinoma
undergoing D2-LAD at two to three times the actual rates
occurring in our patient population. Although this index
was developed to predict the 30-day mortality rate, we
applied it to the 90-day mortality rate as well. Because of
the low mortality rate in our patient cohort, the difference
(3.6% – 5.1%) was irrelevant. An overestimate of mortal-
ity risk using this index has also been found in other stud-
ies, i.e. for patients with esophageal carcinoma, where a
high post-operative mortality is expected [26,27].
Despite these discouraging results, there was a significant
correlation of the predicted risk of severe morbidity
(including mortality) with the actual incidence using the
R1 index. This correlation was evident in all three of the
classified risk levels, where the observed outcomes agreed
completely with the predicted risk for severe morbidity. In
light of these results, the R1 classification appears to be
suitable for risk stratification purposes in clinical studies.
The calculated POSSUM-Morbidity Index (R2) overesti-
mated the risk of developing post-operative complica-
tions in this study. There is an acceptable correlation
between predicted values and observed rates of morbidity
when using the R2 to evaluate both very low risk patients
and very high-risk patients. In the other categories, how-
ever, the risk was overestimated two to three-fold.
The POSSUM Score is used to predict the post-operative
course of patients, using both the pre-operative assess-
ment of the severity of pre-existing concomitant medical
conditions as well as information gathered during the
peri-operative period i.e. severity of surgical insult, intra-
operative blood loss, etc. However, peri-operative infor-
mation was not available pre-operatively; the decision
regarding magnitude of gastrectomy had not yet been
made. Therefore, our investigation focused on whether
application of the POSSUM Physiological Score would be
sufficient to make an accurate pre-operative prediction.
The V-POSSUM Score, which was previously evaluated
primarily for the assessment of patients with vascular dis-
ease [24], was ineffective for predicting post-operative
course in our patient cohort. Using this score we showed,
admittedly, that patients with high PPS scores also had
higher risks of complications or post-operative mortality,
but the correlation was not significant enough to give a
valid pre-operative risk assessment.
There are still more instruments that may be used for risk
assessment of patients with concomitant medical prob-
lems. For example, the Charlson Comorbidity Index
(CCI) was developed particularly to address this issue
[28,29]. This assessment focuses primarily on long-term
outcomes. However, some studies have shown that the
CCI is not suitable for the prediction of post-operative
course [8]. Another assessment instrument, the APACHE
II Score, was developed for patients in the Intensive Care
Unit to predict the courses of patients there [30,31].
Unfortunately, the APACHE Score is irrelevant in our
patient cohort, where some of the assessed parameters do
not exist pre-operatively, or change post-operatively.
Conclusion
This study shows that the POSSUM Mortality Score (R1)
is a suitable instrument to risk stratify patients with gastric
carcinoma undergoing D2-LAD for the development of
severe post-operative complications (including post-oper-
ative mortality), based on pre-existing or concomitant
medical problems. The POSSUM Morbidity Index (R2) is
particularly suitable for risk assessment if the target
parameters include moderate to severe complications.
When using this instrument, however, the overestimation
of risk must be considered. For our purposes, none of the
instruments (i.e. PPS, V-POSSUM) examined for pre-oper-
ative risk assessment were effective models. Finally, in our
study we showed that accurate documentation of stand-
ardized risk scores is possible under routine conditions
and that the necessary parameters for a second score like
the POSSUM Score could be formulated.
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